Home > Boards > US Listed > Biotechs > MERSANA THERAPEUTICS, INC. (MRSN)

MRSN...all green lights for me...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jaybe Member Profile
 
Followed By 5
Posts 285
Boards Moderated 0
Alias Born 05/29/11
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/16/2021 6:02:00 AM
Is Mersana Stock a Buy Right Now? This Is What You Need to Know TipRanks - 9/13/2021 4:20:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2021 7:51:32 AM
Mersana Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 9/7/2021 8:00:00 AM
Mersana Therapeutics to Provide Update on the Progress of its UpRi Clinical Development Strategy and Report Interim Data from the Ovarian Cancer Expansion Cohort of the UpRi Phase I Study GlobeNewswire Inc. - 9/1/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:31:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/18/2021 4:32:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/18/2021 4:31:25 PM
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 8/18/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 8:17:02 AM
Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer GlobeNewswire Inc. - 8/16/2021 8:00:00 AM
Mersana Therapeutics EPS misses by $0.09 Seeking Alpha - 8/6/2021 6:04:38 AM
Mersana Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update GlobeNewswire Inc. - 8/6/2021 6:00:00 AM
Mersana Therapeutics to Present at the 12th Annual Wedbush PacGrow Healthcare Conference GlobeNewswire Inc. - 8/4/2021 8:00:00 AM
Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2021 Financial Results and Business Updates GlobeNewswire Inc. - 7/30/2021 8:00:00 AM
Mersana Therapeutics Announces Initiation of the UPGRADE Phase 1 Platinum Combination Cohort for UpRi in Platinum-Sensitive Ovarian Cancer GlobeNewswire Inc. - 7/28/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:32:28 PM
The Bottom Is in for These 2 Stocks? Analysts Say ‘Buy’ TipRanks - 6/29/2021 11:13:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2021 4:31:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2021 6:31:32 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 6:36:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 6:04:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 6:04:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 6:03:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 6:02:44 PM
jaybe   Sunday, 07/16/17 02:36:27 PM
Re: None
Post # of 42 
MRSN...all green lights for me...

Award-winning platform, outstanding pre-clinical with proven MOAs and targets, strong team, multi-billion dollar markets for both lead compounds consisting of several potential indications.

Will have 3-4 candidates in clinic by end of 2018, 2 internal and 1-2 with partners (Merck KgaA and/or Takeda). Recent IPO (June) with steady flow of milestones (up to $2B) from partnerships.

Looking at a 5-year 10-bagger here...good luck to all.

Will post often here.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences